Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4696454010 | Product containing only levocloperastine in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4696455011 | Levocloperastine only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Levocloperastine only product in oral dose form | Is a | Levocloperastine only product | true | Inferred relationship | Some | ||
| Levocloperastine only product in oral dose form | Is a | Levocloperastine-containing product in oral dose form | true | Inferred relationship | Some | ||
| Levocloperastine only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Levocloperastine only product in oral dose form | Has active ingredient | Levocloperastine | true | Inferred relationship | Some | 1 | |
| Levocloperastine only product in oral dose form | Plays role | Antitussive therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Levocloperastine fendizoate 7.08 mg/mL oral suspension | Is a | True | Levocloperastine only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR